Table 3 Analysis of the use of macrolide antibiotics in MP-nonPB and MP-PB groups
From: Characteristics of plastic bronchitis in children with infectious pneumonia
MP-nonPB group (n = 79) | MP-PB group (n = 22) | P | ||
|---|---|---|---|---|
Sex (F/M) | 27/52 | 8/14 | 0.849 | |
Age (Mean ± SD,years) | 7.3 ± 2.2 | 7.1 ± 1.8 | 0.767 | |
Distribution of age | 2–5 years [n(%)] | 13(16.5%) | 5(22.7%) | 0.534 |
6–9 years [n(%)] | 54(68.3%) | 17(77.3%) | 0.418 | |
10–13 years [n(%)] | 12(15.2%) | 0(0%) | 0.064 | |
Macrolide antibiotics treatment | Frequency of pre-hospitalization [n(%)] | 79(100%) | 22(100%) | |
Disease course of initial use (days) | 2.7 ± 1.3 | 4.4 ± 2.6 | 0.008 | |
1–3[n(%)] | 62(78.5%) | 10(45.4%) | 0.002 | |
4–6[n(%)] | 16(20.2%) | 8(36.4%) | 0.116 | |
7–10[n(%)] | 1(1.3%) | 4(18.2%) | 0.008 | |
Pre-hospitalization treatment duration (days) | 2.9 ± 1.3 | 5.6 ± 2.4 | 0.001 |